|
Treatment of polycythemia vera.(Tips)(Author Abstract)
From:
American Family Physician
| Date:
October 1, 2003| Author:
Carter, Chuck
| COPYRIGHT 2003 American Academy of Family Physicians. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
Polycythemia vera (PV) is one of three chronic myeloproliferative disorders, along with essential thrombocythemia and myelofibrosis with myeloid metaplasia. The incidence of PV is 2.3 per 100,000 patients, and the median age at diagnosis is 60 years. Tefferi recommends treatment options for PV.
Polycythemia describes an increase in red blood cell mass. The increase in red blood cell mass may be caused by an actual increase in red blood cell mass (true polycythemia) or a ...
Related newspaper, magazine, and journal articles from HighBeam Research